Difficulty: Medium
Average Score: 63%
Practice
In case of liver disorders accompanied by a decline in microsomal enzyme activity the duration of action of some drugs is:
Correct answer
B
Rationale
In the case of liver disorders accompanied by a decline in microsomal enzyme activity, the duration of action of some drugs is **enlarged**. This is because microsomal enzymes, primarily found in the liver, play a crucial role in metabolizing many drugs. When their activity is reduced due to liver dysfunction, the breakdown of drugs slows down, leading to a longer duration of action.
Option A) **Decreased** is incorrect because a decline in microsomal enzyme activity would not speed up the breakdown of drugs, resulting in a decreased duration of action.
Option C) **Remained unchanged** is incorrect because if the liver's ability to metabolize drugs is compromised, it would impact the duration of action of drugs, making this option inaccurate.
Option D) **Changed insignificantly** is incorrect because a decline in microsomal enzyme activity can significantly alter the pharmacokinetics of drugs, affecting their duration of action.
Understanding the impact of liver disorders on drug metabolism is vital for healthcare professionals to ensure appropriate dosing and monitoring of pharmacological treatments in clients across the lifespan. This knowledge is crucial in preventing adverse effects and optimizing therapeutic outcomes, especially in vulnerable populations such as the elderly or pediatric patients.
Option A) **Decreased** is incorrect because a decline in microsomal enzyme activity would not speed up the breakdown of drugs, resulting in a decreased duration of action.
Option C) **Remained unchanged** is incorrect because if the liver's ability to metabolize drugs is compromised, it would impact the duration of action of drugs, making this option inaccurate.
Option D) **Changed insignificantly** is incorrect because a decline in microsomal enzyme activity can significantly alter the pharmacokinetics of drugs, affecting their duration of action.
Understanding the impact of liver disorders on drug metabolism is vital for healthcare professionals to ensure appropriate dosing and monitoring of pharmacological treatments in clients across the lifespan. This knowledge is crucial in preventing adverse effects and optimizing therapeutic outcomes, especially in vulnerable populations such as the elderly or pediatric patients.